• Je něco špatně v tomto záznamu ?

Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts

A. Skálová, A. Agaimy, T. Vanecek, M. Baněčková, J. Laco, N. Ptáková, P. Šteiner, H. Majewska, W. Biernat, L. Corcione, V. Eis, O. Koshyk, J. Vondrák, M. Michal, I. Leivo

. 2021 ; 45 (1) : 1-13. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011633

Myoepithelial carcinoma of salivary glands is an underrecognized and challenging entity with a broad morphologic spectrum, including an EWSR1-rearranged clear cell variant. Myoepithelial carcinoma is generally aggressive with largely unknown genetic features. A retrospective review of Salivary Gland Tumor Registry in Pilsen searching for the key words "clear cell myoepithelial carcinoma," "hyalinizing clear cell," and "clear cell malignant myoepithelioma" yielded 94 clear cell myoepithelial carcinomas (CCMCs) for molecular analysis of EWSR1 rearrangement using fluorescence in situ hybridization (FISH). Tumors positive for EWSR1 gene rearrangement were tested by next-generation sequencing (NGS) using fusion-detecting panels. NGS results were confirmed by reverse-transcription polymerase chain reaction or by FISH. Twenty-six tumors originally diagnosed as CCMC (26/94, 27.6%) revealed split signals for EWSR1 by FISH. Six of these tumors (6/26, 23%) displayed amplification of the EWSR1 locus. Fifteen cases were analyzable by NGS, whereas 9 were not, and tissue was not available in 2 cases. None of the CCMCs with EWSR1 rearrangements detected by FISH had an EWSR1 fusion transcript. Fusion transcripts were detected in 6 cases (6/15, 40%), including LIFR-PLAG1 and CTNNB1-PLAG1, in 2 cases each, and CHCHD7-PLAG1 and EWSR1-ATF1 fusions were identified in 1 case each. Seven cases, including those with PLAG1 fusion, were positive for PLAG1 rearrangement by FISH, with notable exception of CHCHD7-PLAG1, which is an inversion not detectable by FISH. One single case with EWSR1-ATF1 fusion in NGS showed ATF1 gene rearrangement by FISH and was reclassified as clear cell carcinoma (CCC). In addition, another 4 cases revealed ATF1 rearrangement by FISH and were reclassified as CCC as well. Moreover, 12/68 (17%) CCMCs with intact EWSR1 gene were selected randomly and analyzed by NGS. PLAG1 fusions were found in 5 cases (5/12, 41.6%) with LIFR (2 cases), FGFR1 (2 cases), and CTNNB1 (1 case) as partner genes. Overall, PLAG1 gene rearrangements were detected in 10/38 (26%) tested cases. None of the tumors had SMARCB1 loss by immunohistochemistry as a possible explanation for the EWSR1 abnormalities in FISH. Novel findings in our NGS study suggest that EWSR1-FISH positive CCMC is a gene fusion-driven disease with frequent oncogenic PLAG1 fusions, including LIFR-PLAG1 and CTNNB1-PLAG1 in most cases. Productive EWSR1 fusions are found only in a minority of EWSR1-ATF1-rearranged cases, which were in part reclassifiable as CCCs. Detectable EWSR1-FISH abnormality in CCMCs without gene fusion perhaps represents a passenger mutation with minor or no oncologic effect.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011633
003      
CZ-PrNML
005      
20210507104601.0
007      
ta
008      
210420s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAS.0000000000001591 $2 doi
035    __
$a (PubMed)33027073
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Skálová, Alena $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University $u Bioptic Laboratory Ltd
245    10
$a Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts / $c A. Skálová, A. Agaimy, T. Vanecek, M. Baněčková, J. Laco, N. Ptáková, P. Šteiner, H. Majewska, W. Biernat, L. Corcione, V. Eis, O. Koshyk, J. Vondrák, M. Michal, I. Leivo
520    9_
$a Myoepithelial carcinoma of salivary glands is an underrecognized and challenging entity with a broad morphologic spectrum, including an EWSR1-rearranged clear cell variant. Myoepithelial carcinoma is generally aggressive with largely unknown genetic features. A retrospective review of Salivary Gland Tumor Registry in Pilsen searching for the key words "clear cell myoepithelial carcinoma," "hyalinizing clear cell," and "clear cell malignant myoepithelioma" yielded 94 clear cell myoepithelial carcinomas (CCMCs) for molecular analysis of EWSR1 rearrangement using fluorescence in situ hybridization (FISH). Tumors positive for EWSR1 gene rearrangement were tested by next-generation sequencing (NGS) using fusion-detecting panels. NGS results were confirmed by reverse-transcription polymerase chain reaction or by FISH. Twenty-six tumors originally diagnosed as CCMC (26/94, 27.6%) revealed split signals for EWSR1 by FISH. Six of these tumors (6/26, 23%) displayed amplification of the EWSR1 locus. Fifteen cases were analyzable by NGS, whereas 9 were not, and tissue was not available in 2 cases. None of the CCMCs with EWSR1 rearrangements detected by FISH had an EWSR1 fusion transcript. Fusion transcripts were detected in 6 cases (6/15, 40%), including LIFR-PLAG1 and CTNNB1-PLAG1, in 2 cases each, and CHCHD7-PLAG1 and EWSR1-ATF1 fusions were identified in 1 case each. Seven cases, including those with PLAG1 fusion, were positive for PLAG1 rearrangement by FISH, with notable exception of CHCHD7-PLAG1, which is an inversion not detectable by FISH. One single case with EWSR1-ATF1 fusion in NGS showed ATF1 gene rearrangement by FISH and was reclassified as clear cell carcinoma (CCC). In addition, another 4 cases revealed ATF1 rearrangement by FISH and were reclassified as CCC as well. Moreover, 12/68 (17%) CCMCs with intact EWSR1 gene were selected randomly and analyzed by NGS. PLAG1 fusions were found in 5 cases (5/12, 41.6%) with LIFR (2 cases), FGFR1 (2 cases), and CTNNB1 (1 case) as partner genes. Overall, PLAG1 gene rearrangements were detected in 10/38 (26%) tested cases. None of the tumors had SMARCB1 loss by immunohistochemistry as a possible explanation for the EWSR1 abnormalities in FISH. Novel findings in our NGS study suggest that EWSR1-FISH positive CCMC is a gene fusion-driven disease with frequent oncogenic PLAG1 fusions, including LIFR-PLAG1 and CTNNB1-PLAG1 in most cases. Productive EWSR1 fusions are found only in a minority of EWSR1-ATF1-rearranged cases, which were in part reclassifiable as CCCs. Detectable EWSR1-FISH abnormality in CCMCs without gene fusion perhaps represents a passenger mutation with minor or no oncologic effect.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a genová přestavba $7 D015321
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a myoepiteliální nádor $x genetika $7 D009208
650    _2
$a onkogenní fúze $7 D050596
650    _2
$a protein EWS vázající RNA $x genetika $7 D034802
650    _2
$a nádory slinných žláz $x genetika $7 D012468
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Agaimy, Abbas $u Department of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital of Erlangen, Erlangen, Germany
700    1_
$a Vanecek, Tomas $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
700    1_
$a Baněčková, Martina $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University $u Bioptic Laboratory Ltd
700    1_
$a Laco, Jan $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove
700    1_
$a Ptáková, Nikola $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
700    1_
$a Šteiner, Petr $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
700    1_
$a Majewska, Hanna $u Department of Pathology, Warmia nad Mazury University, Olsztyn
700    1_
$a Biernat, Wojciech $u Department of Pathology, Medical University of Gdansk, Gdansk, Poland
700    1_
$a Corcione, Luigi $u Department of Pathology, University of Parma, Parma, Italy
700    1_
$a Eis, Václav $u Department of Pathology, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague
700    1_
$a Koshyk, Olena $u Medical Laboratory CSD, Kyiv, Ukraine
700    1_
$a Vondrák, Jan $u Molecular and Genetic Laboratory, South Bohemian University, Ceske Budejovice, Czech Republic
700    1_
$a Michal, Michal $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University
700    1_
$a Leivo, Ilmo $u Institute of Biomedicine, University of Turku $u Department of Pathology, Turku University Hospital, Turku, Finland
773    0_
$w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 45, č. 1 (2021), s. 1-13
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33027073 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104559 $b ABA008
999    __
$a ok $b bmc $g 1650104 $s 1132012
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 45 $c 1 $d 1-13 $e - $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace